Elly Gerald Stoica

Array ( [id] => 9930906 [patent_doc_number] => 20150079097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/553554 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 41596 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14553554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932364 [patent_doc_number] => 20150080556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/551660 [patent_app_country] => US [patent_app_date] => 2014-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19373 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14551660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11184775 [patent_doc_number] => 09416167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Stable liquid formulations of dimer VEGF antagonists' [patent_app_type] => utility [patent_app_number] => 14/550385 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5625 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10234332 [patent_doc_number] => 20150119326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'ADMINISTRATION OF ANGIOCIDIN FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/522750 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9137 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14522750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864144 [patent_doc_number] => 20150044163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'A Method for Cuticle Growth using Granulocyte-Colony Stimulating Factor' [patent_app_type] => utility [patent_app_number] => 14/522559 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8305 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14522559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208366 [patent_doc_number] => 20150093355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 14/517254 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8867 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421330 [patent_doc_number] => 20170029474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'POLYPEPTIDE AND ANTI-TUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 15/112756 [patent_app_country] => US [patent_app_date] => 2014-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6214 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838525 [patent_doc_number] => 20150030606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'ACTRIIB BINDING AGENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/508988 [patent_app_country] => US [patent_app_date] => 2014-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23158 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343690 [patent_doc_number] => 09528089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Method for increasing the proportion of animal cells secreting galectin-9' [patent_app_type] => utility [patent_app_number] => 14/499736 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 100 [patent_no_of_words] => 38228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343690 [patent_doc_number] => 09528089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Method for increasing the proportion of animal cells secreting galectin-9' [patent_app_type] => utility [patent_app_number] => 14/499736 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 100 [patent_no_of_words] => 38228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343690 [patent_doc_number] => 09528089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Method for increasing the proportion of animal cells secreting galectin-9' [patent_app_type] => utility [patent_app_number] => 14/499736 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 100 [patent_no_of_words] => 38228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343690 [patent_doc_number] => 09528089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Method for increasing the proportion of animal cells secreting galectin-9' [patent_app_type] => utility [patent_app_number] => 14/499736 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 100 [patent_no_of_words] => 38228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040201 [patent_doc_number] => 20160237158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'Methods and Compositions for Targeting Tumor Microenvironment and for preventing Metastasis' [patent_app_type] => utility [patent_app_number] => 15/023806 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23869 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491527 [patent_doc_number] => 20170065713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'IMMUNOGENIC PEPTIDES FOR INHIBITION AND TREATMENT OF HERPES SIMPLEX VIRUS INFECTION AND CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/493070 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7635 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932108 [patent_doc_number] => 20150080300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'GROWTH FACTOR CONCENTRATE AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/487113 [patent_app_country] => US [patent_app_date] => 2014-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9909018 [patent_doc_number] => 20150064219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY USING FLAGELLIN-TUMOR ASSOCIATED ANTIGEN FUSION PROTEIN EXPRESSING TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/484374 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15623 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930839 [patent_doc_number] => 20150079031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'Use of Pegylated IL-10 to Treat Cancer' [patent_app_type] => utility [patent_app_number] => 14/485315 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12144 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930887 [patent_doc_number] => 20150079079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'Methods and Compositions for Treatment of Chlamydial Infection and Related Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 14/483961 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 20330 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11023736 [patent_doc_number] => 20160220692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 14/917744 [patent_app_country] => US [patent_app_date] => 2014-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10968 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11784994 [patent_doc_number] => 09394339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation' [patent_app_type] => utility [patent_app_number] => 14/477925 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13207 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14477925 [rel_patent_id] =>[rel_patent_doc_number] =>)